• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

New RNA expression-based diagnostic test highly sensitive for childhood TB

byTomi Jun
May 1, 2014
in Infectious Disease, Pediatrics, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD 

1. An RNA expression signature for active TB in children had higher sensitivity than the PCR-based Xpert MTB/RIF assay, but lower specificity. 

Evidence Rating Level: 1 (Excellent) 

Study Rundown: Childhood tuberculosis (TB) presents a diagnostic challenge. In adults, the diagnosis is typically made by detection of acid-fast bacilli in a sputum sample. In children, the disease presents with fewer bacilli and microbiological confirmation of the organism is possible in only about 40% of cases.

In this study, the authors compared RNA transcripts between children with culture-confirmed TB, children with latent TB and children with diseases other than TB to identify RNA transcript signatures that could distinguish active TB from latent TB and other diseases. This RNA-based risk score had a sensitivity and specificity of 82.9% and 83.6% for culture-confirmed TB. The PCR-based Xpert MTB/RIF test had a sensitivity and specificity of 54.3% and 100%.

Although this RNA-based signature offers improved sensitivity, the complexity and cost of the technology behind it still limits its application to resource-poor settings. It should also be borne in mind that the gold standard for TB diagnosis in children is poor, as described above. Comparing new diagnostic tests to this weak gold standard is therefore an inherently limited approach. Outcomes data showing that these molecular tests can reduce under- and over-treatment would be even more compelling.

Click to read the study in NEJM

RELATED REPORTS

#VisualAbstract: Non-severe tuberculosis in children can be treated with a shorter 4-month regimen instead of 6-month regimen

Non-severe tuberculosis in children can be treated with a shorter 4-month regimen

#VisualAbstract: Rifapentine-moxifloxacin noninferior to standard of care treatment for pulmonary tuberculosis

Relevant Reading: Tuberculosis in children

In-Depth: Three hundred and forty-six children in South Africa and Malawi formed the discovery cohort in which the RNA transcript signature for TB was determined. Fifty-one transcripts distinguished the children with TB from the children with other diseases and 42 distinguished active TB from latent TB.

A risk score based on the transcript levels was developed and validated in a cohort of 157 children in Kenya. The risk score was evaluated in children with culture-confirmed TB and in children with other diseases and a sensitivity and specificity of 82.9% and 83.6% were found.

The risk score was also tested among children with culture-negative TB, that is, children who were treated for TB based on clinical suspicion alone. In these cases the effective sensitivity was calculated based on estimated prevalence of actual tuberculosis. The RNA-based risk score had better sensitivity than the Xpert MTB/RIF assay in all cases.

More from this author: Early risk factor for progression of cystic fibrosis identified, Gut microbes implicated in stroke and heart attacks: new dietary link, New leukemia mutation offers therapeutic targets, Childhood ADHD associated with increased risk of suicide, A marker of aggressive liver cancer and potential therapeutic target identified 

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: tuberculosis
Previous Post

AAP recommends child life services

Next Post

Structural and neurobiological foundations of suicide, a review

RelatedReports

#VisualAbstract: COVID-19 vaccines provided durable protection from COVID-19, but their effectiveness waned over time in North Carolina
StudyGraphics

#VisualAbstract: Non-severe tuberculosis in children can be treated with a shorter 4-month regimen instead of 6-month regimen

April 13, 2022
Updated review confirms efficacy and safety of most standard treatments for latent tuberculosis infection
Chronic Disease

Non-severe tuberculosis in children can be treated with a shorter 4-month regimen

March 16, 2022
#VisualAbstract: Rifapentine-moxifloxacin noninferior to standard of care treatment for pulmonary tuberculosis
StudyGraphics

#VisualAbstract: Rifapentine-moxifloxacin noninferior to standard of care treatment for pulmonary tuberculosis

May 18, 2021
Updated review confirms efficacy and safety of most standard treatments for latent tuberculosis infection
Chronic Disease

Rifapentine-moxifloxacin noninferior to standard of care treatment for pulmonary tuberculosis

May 10, 2021
Next Post
CTA as an alternative to angiography for blunt cerebrovascular trauma detection

Structural and neurobiological foundations of suicide, a review

Patient transfers to trauma centers often unnecessary

Newspaper reporting of suicide linked with teenage suicide clusters

Ethnic disparities in HPV 16/18-positive high-grade cervical lesions

Partners of HPV-Oropharyngeal cancer patients not at increased HPV risk

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stereotactic body radiotherapy as a state of the art treatment option in inoperable non-small cell lung cancer [Classics Series]
  • Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers
  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.